Press Release

PharPoint Awarded Position on The Triangle Business Journal’s “Best Place to Work” List for 2024

For the second year in a row, PharPoint has been recognized as one of the best places to work in the Raleigh/Durham/Research Triangle Park area.

June 5, 2024
View the Post

Stacey Smith Will, CCRA, Joins PharPoint as Sr. Director of Clinical Operations

Ms. Will joins PharPoint as the company continues to grow and engage an increasing number of biotech and pharmaceutical clients seeking personalized attention, therapeutically aligned expertise, industry-best timelines, and decentralized study options.

March 1, 2021
View the Post

COVID-19: Update from PharPoint Research

As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health.

March 16, 2020
View the Post

Turn Therapeutics featured on WorldWide Business with kathy ireland

Last October, Turn Therapeutics was featured on Worldwide Business with kathy ireland®, where Turn founder and CEO Bradley Burnam shared his unique story of what makes Turn Therapeutics product different. PharPoint Research is proud to have worked with the Turn Therapeutics team as they continue to improve the lives and treatment options for patients of infectious disease.

October 1, 2019
View the Post

PharPoint Incorporates EDC Software Medrio into Data Management Offerings

Explore how PharPoint Research integrates Medrio’s EDC software into its data management offerings to enhance clinical trial efficiency. Discover the benefits of streamlined data collection, improved accuracy, and accelerated study timelines with Medrio’s innovative solutions.

October 9, 2011
View the Post

PharPoint joins Medidata Solutions’ CRO partner program

Medidata Solutions announced that PharPoint has joined Medidata’s ASPire to Win® channel partner program.

October 9, 2010
View the Post